Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Pharmacopsychiatry ; 52(3): 148-154, 2019 Mar.
Article in English | MEDLINE | ID: mdl-29590682

ABSTRACT

INTRODUCTION: Pharmaceutical oxytocin (OT) administration is being tested as a novel treatment for social deficits in various psychiatric populations. However, little is known about how naturally occurring variation in peripheral OT relates to differences in social cognition. This study investigates whether healthy individuals with very high or very low levels of empathy differ in endogenous OT and whether OT plasma levels can predict performance in a mentalizing task. METHODS: 40 healthy men were included based upon their score above the 85th or below the 15th percentile of the empathy quotient inventory 1. Participants' abilities to interpret social information was assessed via the Social Detection Task 2. Plasma OT levels were analyzed using enzyme immunoassay. RESULTS: OT plasma levels predicted mentalizing performance for more ambiguous social scenes (i. e., difficult items) for all participants. We found no group differences in OT plasma levels between subjects with high and low empathy. DISCUSSION: These findings confirm a link between peripheral OT and the ability to read subtle nonverbal social cues in healthy individuals, which is independent of self-reported empathy.


Subject(s)
Cognition/physiology , Empathy/physiology , Oxytocin/blood , Social Behavior , Adult , Correlation of Data , Healthy Volunteers , Humans , Male , Personality Inventory , Surveys and Questionnaires , Young Adult
2.
Diabetes Res Clin Pract ; 123: 165-172, 2017 Jan.
Article in English | MEDLINE | ID: mdl-28024277

ABSTRACT

AIMS: Hypoglycaemia is associated with increased risk of cardiovascular events and mortality in patients with diabetes, but the extent and mechanisms of this link are ill defined. We here prospectively studied cardiac repolarization abnormalities during insulin-induced hypoglycaemia in humans. METHODS: 119 individuals (69 males, age 47.5±13.4years, range 18-82years) were assessed during hypoglycaemia after the injection of 0.1-0.25units/kg human insulin. Corrected QT intervals (QTc) and QT dispersion (QTd) were calculated from serially recorded twelve lead electrocardiograms, and plasma glucose and other endocrine markers were studied. RESULTS: QTc increased from 415.1±21.9ms (mean±standard deviation) at baseline to 444.9±26.5ms during hypoglycaemia (plasma glucose nadir, 1.6±0.5mmol/L, p=0.001), accompanied by an increase of QTd from 45.0±22.7ms to 64.1±40.0ms (p<0.001). Hypoglycaemia-induced abnormal QTc prolongation (defined as ⩾460ms in females and ⩾450ms in males) occurred in 17% (9/54) of females and 26% (17/65) of males. 97 of 119 of individuals (82%) developed transient hypokalaemia (K+ ⩽3.6mmol/L), and plasma epinephrine increased from 220.4±169.5pmol/L at baseline to 2945.6±2421.4pmol/L during hypoglycaemia. Baseline QTc, but not age or gender, was a significant predictor of hypoglycaemia-induced QTc prolongation (p=0.001). CONCLUSIONS: Insulin-induced hypoglycaemia frequently causes abnormal QT prolongation and is associated with hypokalaemia and sympathoadrenal activation, thereby increasing the potential risk for ventricular arrhythmias, particularly in individuals with pre-existing high normal QTc.


Subject(s)
Arrhythmias, Cardiac/etiology , Electrocardiography/methods , Hypoglycemia/chemically induced , Insulin, Regular, Human/adverse effects , Adolescent , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Young Adult
3.
J Clin Endocrinol Metab ; 100(9): 3460-9, 2015 Sep.
Article in English | MEDLINE | ID: mdl-26091204

ABSTRACT

CONTEXT: The best treatment of primary hypophysitis (PrHy) is a matter of debate. OBJECTIVE: Our main objective was to analyze the treatment practice for PrHy in Germany and to compare the outcome of the main treatment options. DESIGN: The Pituitary Working Group of the German Society of Endocrinology conducted a nationwide retrospective cross-sectional cohort study. PATIENTS: Seventy-six patients with PrHy were eligible for the study. MAIN OUTCOME MEASURES: Clinical and endocrinological outcomes, side effects and complications of therapy, initial response, and recurrence rates were assessed. Outcome depending on the treatment modality was evaluated. RESULTS: For mere observation, regression of space-occupying lesions was observed in 46%, unchanged size in 27%, and progression reported in 27%. Pituitary function improved in 27% of patients during observation. Deterioration of pituitary function was only found in patients with progressive lesions. The initial response to glucocorticoid pulse therapy was most favorable, with early failure in only 3%. However, the overall failure and recurrence rate was 41%. Recurrence rate was not related to duration of steroid administration. Side effects of steroids occurred in 63%. The surgical approach was transsphenoidal in 94%. The histological subtype was lymphocytic hypophysitis in 70% and granulomatous hypophysitis in 30%. Progression or recurrence was observed in 25% after surgical treatment. CONCLUSION: Glucocorticoid pulse therapy is associated with a high recurrence rate. Evidence suggests that surgery is not able to prevent recurrence. Considering the favorable results of observation, conservative management is recommended in PrHy unless symptoms are severe or progressive.


Subject(s)
Autoimmune Hypophysitis/therapy , Hypopituitarism/therapy , Pituitary Gland/surgery , Adult , Aged , Autoimmune Hypophysitis/drug therapy , Autoimmune Hypophysitis/surgery , Cross-Sectional Studies , Female , Germany , Glucocorticoids/therapeutic use , Humans , Hypopituitarism/drug therapy , Hypopituitarism/surgery , Male , Retrospective Studies , Treatment Outcome
4.
Cytokine ; 55(2): 195-201, 2011 Aug.
Article in English | MEDLINE | ID: mdl-21531147

ABSTRACT

Proinflammatory cytokines produced by immune cells destroy pancreatic beta cells in type 1 diabetes. The aim of this study was to investigate the cytokine network and its effects in insulin-secreting cells. INS1E cells were exposed to different combinations of proinflammatory cytokines. Cytokine toxicity was estimated by MTT assay and caspase activation measurements. The NFκB-iNOS pathway was analyzed by a SEAP reporter gene assay, Western-blotting and nitrite measurements. Gene expression analyses of ER stress markers, Chop and Bip, were performed by real-time RT-PCR. Cytokines tested in this study, namely IL-1ß, TNFα and IFNγ, had deleterious effects on beta cell viability. The most potent toxicity exhibited IL-1ß and its combinations with other cytokines. The toxic effects of IL-1ß towards cell viability, caspase activation and iNOS activity were dependent on nitric oxide and abolished by an iNOS blocker. IL-1ß was the strongest inducer of the NFκB activation. An iNOS blocker inhibited IL-1ß-mediated NFκB activation in the first, initial phase of cytokine action, but did not affect significantly NFκB activation after prolonged incubation. Interestingly iNOS protein expression was induced predominantly by IL-1ß and decreased in the presence of an iNOS blocker in the case of a short time exposure. The changes in the expression of ER stress markers were also almost exclusively dependent on the IL-1ß presence and counteracted by iNOS blockade. Thus cytokine-induced beta cell death is primarily IL-1ß mediated with a NO-independent enhancement by TNFα and IFNγ. The deleterious effects on cell viability and function are crucially dependent on IL-1ß-induced nitric oxide formation.


Subject(s)
Cell Death/physiology , Cytokines/pharmacology , Endoplasmic Reticulum/metabolism , Insulin-Secreting Cells/drug effects , Insulin-Secreting Cells/metabolism , Nitric Oxide/metabolism , Stress, Physiological , Animals , Caspase 12/metabolism , Cell Line , Enzyme Activation , Gene Expression/drug effects , Genes, Reporter , Insulin-Secreting Cells/cytology , Interleukin-1beta/genetics , Interleukin-1beta/metabolism , Mice , NF-kappa B/genetics , NF-kappa B/metabolism , Nitric Oxide Synthase Type II/genetics , Nitric Oxide Synthase Type II/metabolism , Nitrites/metabolism , Signal Transduction/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...